Niacin-ER may be overlooked cause of thrombocytopenia

April 10, 2016

(HealthDay)—Extended-release (ER) niacin is associated with progressive and reversible thrombocytopenia, according to a letter to the editor published online March 25 in the American Journal of Hematology.

Casey O' Connell, M.D., from the Keck School of Medicine of the University of Southern California in Los Angeles, and colleagues describe four (average age, 68.8 years) who were on niacin-ER for 20 months to nine years. All four patients developed progressive thrombocytopenia.

The researchers found that platelets recovered quickly after cessation of niacin-ER, with improvement noted within a month of cessation in all four patients. Based on criteria to determine the level of evidence for a causal association, three patients were found to have a "probable" association and one a "definite" association. The patients were on niacin-ER daily for 59 months, on average, at a median dose of 2,250 mg. Platelets recovered by an average of 91.5 × 109/L, with a mean time to response of 136 days. In two of the four patients who were anemic as well as thrombocytopenic, there was a marked improvement in hemoglobin upon discontinuation of niacin-ER.

"In conclusion, Niacin-ER is known to cause reversible thrombocytopenia, but this effect may be insidious and severe and can be accompanied by reversible anemia, both of which may be easily overlooked in with multiple medical conditions and concomitant medications," the authors write.

Explore further: ACC: Niacin/Laropiprant no benefit in vascular disease

More information: Full Text (subscription or payment may be required)

Related Stories

ACC: Niacin/Laropiprant no benefit in vascular disease

March 12, 2013
(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious side effects, according ...

SCCM: circulating histones for most with thrombocytopenia

February 23, 2016
(HealthDay)—Most patients with thrombocytopenia have circulating histones, according to a research letter published online Feb. 22 in the Journal of the American Medical Association to coincide with the Society of Critical ...

Extended elevated recurrence rates for ER-positive breast CA

January 28, 2016
(HealthDay)—Breast cancer patients with estrogen receptor (ER)-positive disease have elevated annualized hazards of recurrence during extended follow-up, according to a study published online Jan. 18 in the Journal of Clinical ...

BADGE exposure can elicit contact allergy reactions

November 6, 2014
(HealthDay)—Exposure to aluminum tubes for pharmaceutical use that are internally lacquered with epoxy resins (ER) based on bisphenol A diglycidyl ether (BADGE) can elicit contact allergy reactions, according to a study ...

Extended-Release niacin raises fasting glucose levels

March 28, 2012
(HealthDay) -- The combination of extended-release niacin (N) with ezetimibe plus simvastatin (E/S) to treat hyperlipidemia is associated with increased fasting glucose (FG) levels compared with E/S alone, but these cases ...

Niacin therapy unhelpful, occasionally harmful, study says

March 9, 2013
A combination drug containing niacin failed to lower the risk of heart attacks or strokes and even proved harmful for some with vascular disease, a study released Saturday reported.

Recommended for you

No sweat required: Team finds hypertension treatment that mimics effect of exercise

October 16, 2018
Couch potatoes rejoice—there might be a way to get the blood pressure lowering benefits of exercise in pill form.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Why heart contractions are weaker in those with hypertrophic cardiomyopathy

October 16, 2018
When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and affects an estimated 1 in 500 ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

Researchers say ritual for orthodox Jewish men may offer heart benefits

October 11, 2018
A pilot study led by researchers at the University of Cincinnati (UC) College of Medicine suggests Jewish men who practice wearing tefillin, which involves the tight wrapping of an arm with leather banding as part of daily ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.